Maccura Biotech: Major shareholder, senior manager reduce stakes

Maccura Biotechnology's major shareholder, Guo Lei, and his concerted parties, including Shanghai Axing Investment Management Co. Ltd., reduced their combined stake. Between August 22 and August 25, 2025, they decreased their holdings by 4,522,100 shares, bringing their total ownership from 6.62% to 5.88%. This follows an earlier reduction between August 4 and August 21, 2025, of 6,055,828 shares, from 7.62% to 6.62%.

Concurrently, senior manager Shi Wei plans to sell up to 150,000 shares, or 0.02% of the company's total share capital, between September 17 and December 16, 2025. This sell-off is attributed to personal funding needs and will be executed via centralized bidding.

These transactions are part of previously disclosed plans and are not expected to alter the company's control, governance structure, or ongoing operations.